France’s Cellectis wins U.S patents for gene editing technology – Reuters
Business Wire (press release) |
France's Cellectis wins U.S patents for gene editing technology
Reuters The United States has granted French cell therapy group Cellectis two patents to deploy a technology known as CRISPR in T cells, which play a key role in the immune response to cancer, the company said on Tuesday. Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T … |
